[
    [
        {
            "time": "",
            "original_text": "产品价格将疯涨？一家受益印度疫情、业绩确定性强却未爆炒的低估药企！",
            "features": {
                "keywords": [
                    "产品价格",
                    "疯涨",
                    "印度疫情",
                    "业绩确定性",
                    "低估药企"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "产品价格将疯涨？一家受益印度疫情、业绩确定性强却未爆炒的低估药企！",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]